{"schema_version":"1.0","type":"article","title":"減重藥物不只看體重了：下一代療法正在瞄準這些方向","url":"https://drugnews.com.tw/articles/2026-05-29-next-generation-obesity-therapy-directions.html","markdown_url":"https://drugnews.com.tw/articles/2026-05-29-next-generation-obesity-therapy-directions.md","lang":"zh-Hant","date":"2026-05-29","publish_at":"2026-05-29T10:30:00+08:00","updated_at":"2026-05-29","category":"商業分析系列","topic":"臨床與 CMC","tags":["減重藥物","GLP-1","肥胖治療","肌肉保留","代謝"],"summary":"下一代減重療法不只比體重下降，也要看肌肉保留、脂肪肝、心血管與代謝共病等更完整臨床價值。","key_points":[],"facts":[],"sections":["減重藥物不只看體重了：下一代療法正在瞄準這些方向","藥時事 與 CMoney 全曜財經共同打造減肥藥賽道投資課程","01｜GLP-1 成功之後，下一步是多重受體激動劑","02｜減重藥物不只要瘦，還要看「減重品質」","03｜減重藥物的價值，正在往合併症延伸","04｜口服藥物，是減重藥物走向大眾化的關鍵","05｜胰澱素與組合療法，讓減重藥物更像代謝管理平台","06｜胜肽藥物偶聯：減重藥物可能不只是激動劑，而是遞送系統","08｜台灣可以怎麼看？不是只有「誰有 GLP-1 藥」才有機會","結語｜下一代減重藥物，不只是讓人變瘦，而是重新定義代謝健康"],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"The evolving landscape of obesity pharmacotherapy - Nature Reviews Drug Discovery","source":"Christoffer Clemmensen","date":"","url":""},{"title":"Our Review on the evolving landscape of obesity pharmacotherapy is now online in Nature Reviews Drug Discovery:  Together with Jonas Odgaard Petersen, Valdemar Brimnes Ingemann Johansen, Brian Finan and Timo Müller, we discuss h","source":"","date":"","url":"https://lnkd.in/evwpfiV9"},{"title":"www.linkedin.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet","source":"","date":"","url":""},{"title":"/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-3, the first head-to-head Phase 3 trial evaluating the safety...","source":"","date":"","url":""},{"title":"www.prnewswire.com","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"News Details","source":"","date":"","url":""},{"title":"https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html","source":"","date":"","url":"https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html"},{"title":"www.novonordisk.com","source":"","date":"","url":""},{"title":"[6]:","source":"","date":"","url":""},{"title":"reuters.com","source":"","date":"","url":""},{"title":"https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-obesity-drug-shows-weight-loss-up-145-mid-stage-study-2025-11-25/","source":"","date":"","url":"https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-obesity-drug-shows-weight-loss-up-145-mid-stage-study-2025-11-25/"},{"title":"www.reuters.com","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：減重藥物不只看體重了：下一代療法正在瞄準這些方向","url":"https://drugnews.com.tw/assets/articles/next-generation-obesity-therapy-directions/dcard-01.webp"},{"alt":"Dcard 原圖：減重藥物不只看體重了：下一代療法正在瞄準這些方向","url":"https://drugnews.com.tw/assets/articles/next-generation-obesity-therapy-directions/dcard-02.webp"},{"alt":"Dcard 原圖：減重藥物不只看體重了：下一代療法正在瞄準這些方向","url":"https://drugnews.com.tw/assets/articles/next-generation-obesity-therapy-directions/dcard-03.png"},{"alt":"Dcard 原圖：減重藥物不只看體重了：下一代療法正在瞄準這些方向","url":"https://drugnews.com.tw/assets/articles/next-generation-obesity-therapy-directions/dcard-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/next-generation-obesity-therapy-directions/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-05-29）。減重藥物不只看體重了：下一代療法正在瞄準這些方向。https://drugnews.com.tw/articles/2026-05-29-next-generation-obesity-therapy-directions.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-05-29-next-generation-obesity-therapy-directions-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}